4519

JP:CO:CHUGAI-PHARM

CHUGAI PHARMACEUTICAL CO., LTD.

  • Stock

Last Close

6,383.00

22/11 06:45

Market Cap

10.45T

Beta: -

Volume Today

2.47M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
118.71B
-
134.05B
12.92%
150.35B
12.16%
173.29B
15.25%
177.25B
2.29%
164.21B
7.36%
163.74B
0.28%
176.01B
7.49%
196.37B
11.57%
250.52B
27.58%
282.84B
12.90%
average payables
50.63B
-
61.12B
20.71%
70.52B
15.39%
75.35B
6.84%
67.93B
9.84%
67.61B
0.47%
74.67B
10.44%
89.02B
19.21%
126.33B
41.92%
181.05B
43.31%
161.15B
10.99%
average receivables
134.30B
-
144.14B
7.33%
159.30B
10.52%
163.10B
2.38%
171.24B
4.99%
177.28B
3.53%
180.60B
1.87%
217.50B
20.43%
304.68B
40.09%
435.15B
42.82%
417.32B
4.10%
book value per share
349.96
-
364.55
4.17%
382.24
4.85%
393.95
3.06%
422.00
7.12%
460.29
9.07%
520.04
12.98%
596.31
14.67%
722.59
21.18%
865.98
19.84%
987.89
14.08%
capex per share
-9.16
-
-11.72
27.96%
-15.43
31.63%
-22.23
44.06%
-27.16
22.17%
-47.30
74.17%
-37.25
21.24%
-37.37
0.30%
-44.32
18.60%
-43.31
2.28%
-45.13
4.20%
capex to depreciation
-1.03
-
-1.29
24.73%
-1.62
25.99%
-2.23
37.11%
-2.73
22.51%
-2.34
-
capex to operating cash flow
-0.28
-
-0.52
85.11%
-0.40
22.42%
-0.94
133.87%
-0.41
55.94%
-0.65
57.66%
-0.30
54.61%
-0.30
1.17%
-0.26
13.00%
-0.29
11.99%
-0.18
38.14%
capex to revenue
-0.04
-
-0.04
17.68%
-0.05
21.84%
-0.07
46.24%
-0.08
12.54%
-0.13
60.72%
-0.09
33.45%
-0.08
12.47%
-0.07
6.60%
-0.06
22.42%
-0.07
18.17%
cash per share
143.64
-
140.70
2.05%
144.21
2.50%
125.44
13.02%
148.26
18.19%
151.87
2.43%
202.82
33.55%
230.38
13.59%
287.07
24.60%
305.87
6.55%
449.09
46.82%
days of inventory on hand
250.92
-
233.60
6.90%
244.82
4.80%
272.99
11.51%
242.77
11.07%
221.29
8.85%
230.63
4.22%
245.45
6.42%
225.42
8.16%
223.95
0.65%
241.52
7.85%
days payables outstanding
116.24
-
104.93
9.72%
119.04
13.45%
106.50
10.54%
91.21
14.35%
99.57
9.16%
106.50
6.96%
134.00
25.82%
164.36
22.65%
160.82
2.15%
99.32
38.24%
days sales outstanding
110.61
-
126.56
14.42%
116.13
8.24%
124.31
7.04%
119.57
3.81%
113.04
5.46%
96.62
14.53%
117.51
21.62%
129.97
10.61%
148.99
14.63%
105.21
29.38%
debt to assets
0.00
-
0.00
13.41%
0.00
222.58%
0.00
14.30%
0.00
50.73%
0.00
40.68%
debt to equity
0.00
-
0.00
11.92%
0.00
227.13%
0.00
14.92%
0.00
51.40%
0.00
41.42%
dividend yield
0.02
-
0.02
16.00%
0.01
19.21%
0.02
40.98%
0.01
44.87%
0.01
5.19%
0.01
1.91%
0.01
1.03%
0.02
58.87%
0.02
55.32%
0.01
40.00%
earnings yield
0.04
-
0.03
21.50%
0.03
16.29%
0.03
10.72%
0.02
21.16%
0.03
14.86%
0.03
7.83%
0.02
16.85%
0.05
107.81%
0.07
36.98%
0.04
45.22%
enterprise value
1.15T
-
1.50T
30.45%
2.21T
47.37%
1.74T
21.48%
3.01T
73.49%
3.35T
10.97%
5.31T
58.82%
8.83T
66.20%
5.87T
33.50%
5.32T
9.46%
8.33T
56.68%
enterprise value over ebitda
14.96
-
19.71
31.79%
25.34
28.53%
23.31
7.99%
31.04
33.12%
27.52
11.32%
25.54
7.19%
29.61
15.92%
14.00
52.71%
10.01
28.51%
18.83
88.16%
ev to operating cash flow
21.51
-
40.55
88.52%
35.17
13.26%
44.80
27.37%
28.01
37.47%
28.10
0.30%
25.71
8.48%
43.07
67.51%
21.00
51.24%
21.78
3.72%
20.26
7.01%
ev to sales
2.72
-
3.26
19.85%
4.44
36.22%
3.53
20.35%
5.64
59.72%
5.77
2.25%
7.74
34.20%
11.22
44.92%
5.87
47.65%
4.22
28.15%
7.50
77.63%
free cash flow per share
23.60
-
10.93
53.71%
23.00
110.47%
1.44
93.72%
38.48
2,566.20%
25.21
34.48%
88.58
251.34%
87.39
1.34%
125.76
43.90%
105.10
16.43%
204.84
94.90%
free cash flow yield
0.03
-
0.01
63.69%
0.02
47.13%
0.00
92.07%
0.02
1,450.27%
0.01
40.75%
0.03
122.37%
0.02
39.76%
0.03
112.02%
0.03
7.32%
0.04
22.88%
graham net net
166.01
-
170.00
2.40%
168.32
0.99%
161.17
4.25%
182.54
13.26%
183.13
0.32%
212.17
15.86%
246.49
16.17%
299.69
21.58%
358.43
19.60%
491.65
37.17%
graham number
495.30
-
505.69
2.10%
566.64
12.05%
538.44
4.98%
648.91
20.52%
763.74
17.70%
1.06K
38.73%
1.32K
24.96%
1.73K
30.73%
2.11K
21.67%
2.10K
0.44%
income quality
0.53
-
0.37
29.47%
0.57
52.76%
0.38
33.94%
0.86
128.60%
0.78
9.09%
0.83
5.62%
0.60
27.24%
0.59
1.35%
0.42
28.69%
1.26
198.13%
intangibles to total assets
0.01
-
0.02
11.84%
0.02
12.44%
0.02
39.49%
0.02
3.30%
0.02
0.16%
0.02
9.94%
0.02
13.05%
0.01
26.11%
0.01
5.85%
0.01
23.57%
interest coverage
6.56K
-
6.90K
5.10%
1.30K
81.22%
894
30.98%
899.40
0.60%
1.12K
24.53%
1.68K
50.42%
4.86K
188.38%
8.79K
80.91%
8.74K
0.53%
15.21K
73.95%
interest debt per share
0.15
-
0.14
8.25%
0.49
255.98%
0.45
8.92%
0.27
39.03%
0.20
27.02%
0.08
61.66%
0.04
50.44%
0.03
22.61%
0.04
27.03%
0.02
55.76%
inventory turnover
1.45
-
1.56
7.41%
1.49
4.58%
1.34
10.32%
1.50
12.45%
1.65
9.71%
1.58
4.05%
1.49
6.04%
1.62
8.88%
1.63
0.66%
1.51
7.27%
invested capital
0.00
-
0.00
11.92%
0.00
227.13%
0.00
14.92%
0.00
51.40%
0.00
41.42%
market cap
1.27T
-
1.62T
27.61%
2.31T
43.24%
1.83T
20.81%
3.15T
72.10%
3.49T
10.74%
5.52T
57.99%
9.04T
63.91%
6.14T
32.10%
5.54T
9.79%
8.79T
58.68%
net current asset value
380.23B
-
397.12B
4.44%
407.64B
2.65%
418.97B
2.78%
439.56B
4.92%
437.07B
0.57%
494.75B
13.20%
579.41B
17.11%
712.98B
23.05%
891.17B
24.99%
1.06T
18.88%
net debt to ebitda
-1.49
-
-1.49
0.13%
-1.16
22.63%
-1.27
9.93%
-1.43
12.38%
-1.21
15.53%
-0.98
18.73%
-0.71
27.38%
-0.64
10.33%
-0.42
34.49%
-1.04
147.93%
net income per share
31.16
-
31.18
0.07%
37.33
19.74%
32.71
12.39%
44.35
35.59%
56.32
27.00%
95.95
70.36%
130.66
36.18%
184.29
41.05%
227.64
23.52%
197.80
13.11%
operating cash flow per share
32.76
-
22.65
30.87%
38.43
69.67%
23.67
38.40%
65.64
177.29%
72.51
10.47%
125.84
73.54%
124.76
0.86%
170.08
36.32%
148.41
12.74%
249.97
68.43%
payables turnover
3.14
-
3.48
10.77%
3.07
11.85%
3.43
11.78%
4.00
16.76%
3.67
8.40%
3.43
6.50%
2.72
20.52%
2.22
18.47%
2.27
2.20%
3.67
61.91%
receivables turnover
3.30
-
2.88
12.60%
3.14
8.98%
2.94
6.57%
3.05
3.96%
3.23
5.78%
3.78
16.99%
3.11
17.78%
2.81
9.59%
2.45
12.76%
3.47
41.61%
research and ddevelopement to revenue
0.18
-
0.18
0.06%
0.17
4.13%
0.17
2.90%
0.17
0.65%
0.17
1.66%
0.16
8.06%
0.15
4.80%
0.14
8.30%
0.12
13.53%
0.16
32.49%
return on tangible assets
0.07
-
0.07
5.41%
0.08
12.83%
0.07
13.78%
0.09
28.43%
0.10
17.91%
0.15
47.56%
0.18
16.46%
0.20
12.72%
0.20
1.61%
0.17
16.17%
revenue per share
259.34
-
282.00
8.74%
304.67
8.04%
300.13
1.49%
325.81
8.55%
353.07
8.37%
417.86
18.35%
478.84
14.59%
608.08
26.99%
766.00
25.97%
675.40
11.83%
roe
0.09
-
0.09
3.93%
0.10
14.20%
0.08
14.99%
0.11
26.58%
0.12
16.44%
0.18
50.78%
0.22
18.76%
0.26
16.40%
0.26
3.07%
0.20
23.83%
roic
0.09
-
0.09
6.31%
0.10
13.76%
0.09
12.18%
0.11
24.64%
0.13
16.34%
0.19
48.31%
0.22
18.43%
0.26
15.91%
0.26
2.87%
0.19
29.82%
sales general and administrative to revenue
0.03
-
0.03
11.39%
0.03
16.57%
0.02
6.52%
0.03
16.08%
0.03
18.33%
0.04
4.56%
0.03
22.01%
0.03
6.83%
0.02
27.45%
shareholders equity per share
349.96
-
364.55
4.17%
382.24
4.85%
393.95
3.06%
422.00
7.12%
460.29
9.07%
520.04
12.98%
596.31
14.67%
722.59
21.18%
865.98
19.84%
987.89
14.08%
stock based compensation to revenue
tangible asset value
563.69B
-
586.47B
4.04%
613.76B
4.65%
627.20B
2.19%
671.82B
7.11%
733.83B
9.23%
830.45B
13.17%
956.12B
15.13%
1.17T
21.96%
1.40T
20.00%
1.61T
14.76%
tangible book value per share
345.07
-
358.66
3.94%
374.86
4.52%
382.78
2.11%
409.74
7.04%
446.87
9.06%
505.71
13.17%
581.78
15.04%
709.22
21.91%
850.69
19.95%
975.83
14.71%
working capital
406.57B
-
424.55B
4.42%
434.71B
2.39%
455.10B
4.69%
476.24B
4.64%
464.88B
2.39%
520.41B
11.95%
598.84B
15.07%
736.24B
22.95%
912.81B
23.98%
1.08T
18.12%

All numbers in (except ratios and percentages)